KayoThera
Seattle, US · Founded 2019 · 1 known investors
Kayo Therapeutics is a biotechnology company developing therapeutics, with a scientific and clinical focus that includes areas such as metabolic disease and oncology. The company is led by an experienced management team supported by scientific and clinical advisory boards.
BiotechHealthtech
Founders & leadership
TL
Thong LeExecutive Officer, Director
KM
Kendall MohlerExecutive Officer, Director
ME
Mark EspositoCSO, Co-Founder and Board Member
TQ
Thong Q. LePresident and CEO, Board Member
IH
Ian HowesChief Financial Officer
MK
Merika KodayCOO and Board Member
YK
Yibin KangChair, Scientific Advisory Board and Co-Founder
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$10.5MraisedJul 2023 · 14 investors · OtherRule 506(b)
▶$10.5MraisedJul 2023 · 14 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Thong LeExecutive Officer, Director
- Mark EspositoExecutive Officer, Director
- Kendall MohlerExecutive Officer, Director
- Ian HowesExecutive Officer
- Offering amount
- $10.9M
- Amount sold
- $10.5M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$750KraisedJun 2019 · 1 investors · OtherRule 506(b)
▶$750KraisedJun 2019 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Mark EspositoExecutive Officer, Director
- Yibin KangDirector
- George F. HeinrichDirector
- James M. GolubieskiDirector
- Offering amount
- $750K
- Amount sold
- $750K
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.